These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34923039)

  • 1. Specificity of Varenicline in Blocking Mesolimbic Circuit Activation to Natural and Drug Rewards.
    Goldstein N; Carty JRE; Betley JN
    Neuroscience; 2022 Feb; 483():40-51. PubMed ID: 34923039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens.
    Feduccia AA; Simms JA; Mill D; Yi HY; Bartlett SE
    Br J Pharmacol; 2014 Jul; 171(14):3420-31. PubMed ID: 24628360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice.
    Besson M; David V; Baudonnat M; Cazala P; Guilloux JP; Reperant C; Cloez-Tayarani I; Changeux JP; Gardier AM; Granon S
    Psychopharmacology (Berl); 2012 Mar; 220(1):1-14. PubMed ID: 21901321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens.
    Exley R; Clements MA; Hartung H; McIntosh JM; Cragg SJ
    Neuropsychopharmacology; 2008 Aug; 33(9):2158-66. PubMed ID: 18033235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reward Anticipation Is Differentially Modulated by Varenicline and Nicotine in Smokers.
    Fedota JR; Sutherland MT; Salmeron BJ; Ross TJ; Hong LE; Stein EA
    Neuropsychopharmacology; 2015 Jul; 40(8):2038-46. PubMed ID: 25742873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice.
    Bagdas D; Alkhlaif Y; Jackson A; Carroll FI; Ditre JW; Damaj MI
    Neuropharmacology; 2018 Aug; 138():72-79. PubMed ID: 29860196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.
    Spiller K; Xi ZX; Li X; Ashby CR; Callahan PM; Tehim A; Gardner EL
    Neuropharmacology; 2009 Jul; 57(1):60-6. PubMed ID: 19393252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system.
    Ericson M; Löf E; Stomberg R; Söderpalm B
    J Pharmacol Exp Ther; 2009 Apr; 329(1):225-30. PubMed ID: 19126781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic nicotine exposure switches the functional role of mesolimbic dopamine transmission in the processing of nicotine's rewarding and aversive effects.
    Tan H; Bishop SF; Lauzon NM; Sun N; Laviolette SR
    Neuropharmacology; 2009 Mar; 56(4):741-51. PubMed ID: 19133278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributory role for nornicotine in nicotine neuropharmacology: nornicotine-evoked [3H]dopamine overflow from rat nucleus accumbens slices.
    Green TA; Crooks PA; Bardo MT; Dwoskin LP
    Biochem Pharmacol; 2001 Dec; 62(12):1597-603. PubMed ID: 11755112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal dopamine transmission is reduced after chronic nicotine with a decrease in α6-nicotinic receptor control in nucleus accumbens.
    Exley R; Clements MA; Hartung H; McIntosh JM; Franklin M; Bermudez I; Cragg SJ
    Eur J Neurosci; 2013 Oct; 38(7):3036-43. PubMed ID: 23841846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area.
    Nisell M; Nomikos GG; Svensson TH
    Synapse; 1994 Jan; 16(1):36-44. PubMed ID: 8134899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptor blockade modulates the rewarding and aversive properties of nicotine via dissociable neuronal activity patterns in the nucleus accumbens.
    Sun N; Laviolette SR;
    Neuropsychopharmacology; 2014 Nov; 39(12):2799-815. PubMed ID: 24896614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varenicline but not cotinine increased the value of a visual stimulus reinforcer in rats: No evidence for synergy of the two compounds.
    Houser SD; McNealy KR; Barrett ST; Bevins RA
    Pharmacol Biochem Behav; 2024 Feb; 235():173702. PubMed ID: 38154590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized low-level re-expression of high-affinity mesolimbic nicotinic acetylcholine receptors restores nicotine-induced locomotion but not place conditioning.
    Mineur YS; Brunzell DH; Grady SR; Lindstrom JM; McIntosh JM; Marks MJ; King SL; Picciotto MR
    Genes Brain Behav; 2009 Apr; 8(3):257-66. PubMed ID: 19077117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term nicotine treatment down-regulates α6β2* nicotinic receptor expression and function in nucleus accumbens.
    Perez XA; McIntosh JM; Quik M
    J Neurochem; 2013 Dec; 127(6):762-71. PubMed ID: 23992036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct effect of nicotine on mesolimbic dopamine release in rat nucleus accumbens shell.
    Kleijn J; Folgering JH; van der Hart MC; Rollema H; Cremers TI; Westerink BH
    Neurosci Lett; 2011 Apr; 493(1-2):55-8. PubMed ID: 21352892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topography of Reward and Aversion Encoding in the Mesolimbic Dopaminergic System.
    Yuan L; Dou YN; Sun YG
    J Neurosci; 2019 Aug; 39(33):6472-6481. PubMed ID: 31217328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area.
    Laviolette SR; van der Kooy D
    Mol Psychiatry; 2003 Jan; 8(1):50-9, 9. PubMed ID: 12556908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
    West R; Baker CL; Cappelleri JC; Bushmakin AG
    Psychopharmacology (Berl); 2008 Apr; 197(3):371-7. PubMed ID: 18084743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.